BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29228705)

  • 1. YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.
    Andrade D; Mehta M; Griffith J; Panneerselvam J; Srivastava A; Kim TD; Janknecht R; Herman T; Ramesh R; Munshi A
    Oncotarget; 2017 Nov; 8(58):98495-98508. PubMed ID: 29228705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
    Chen L; Xu G; Song X; Zhang L; Chen C; Xiang G; Wang S; Zhang Z; Wu F; Yang X; Zhang L; Ma X; Yu J
    Cancer Lett; 2024 Feb; 583():216635. PubMed ID: 38237887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1/MMP7/CXCL16 axis affects efficacy of neoadjuvant chemotherapy via tumor environment immunosuppression in triple-negative breast cancer.
    Yuan JQ; Zhang KJ; Wang SM; Guo L
    Gland Surg; 2021 Sep; 10(9):2799-2814. PubMed ID: 34733729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
    Zou H; Luo J; Guo Y; Tong T; Liu Y; Chen Y; Xiao Y; Ye L; Zhu C; Deng L; Wang B; Pan Y; Li P
    Cell Mol Life Sci; 2023 Jan; 80(2):41. PubMed ID: 36633714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes-associated protein 1 is required for proliferation and function of bovine granulosa cells in vitro†.
    Plewes MR; Hou X; Zhang P; Liang A; Hua G; Wood JR; Cupp AS; Lv X; Wang C; Davis JS
    Biol Reprod; 2019 Nov; 101(5):1001-1017. PubMed ID: 31350850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7.
    Zou H; Luo J; Guo Y; Liu Y; Wang Y; Deng L; Li P
    Oncogene; 2022 Mar; 41(11):1657-1672. PubMed ID: 35102250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy.
    Guimei M; Alrouh S; Saber-Ayad M; Hafezi SA; Vinod A; Rawat S; Wardeh Y; Bakkour TM; El-Serafi AT
    Breast Cancer (Dove Med Press); 2020; 12():189-199. PubMed ID: 33173331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
    Li Y; Hua K; Jin J; Fang L
    Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.
    Yamazoe M; Ozasa H; Tsuji T; Funazo T; Yoshida H; Hashimoto K; Hosoya K; Ogimoto T; Ajimizu H; Yoshida H; Itotani R; Sakamori Y; Kuninaga K; Aoki W; Hirai T
    Cancer Sci; 2023 Feb; 114(2):546-560. PubMed ID: 36285485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 11. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.
    Song S; Honjo S; Jin J; Chang SS; Scott AW; Chen Q; Kalhor N; Correa AM; Hofstetter WL; Albarracin CT; Wu TT; Johnson RL; Hung MC; Ajani JA
    Clin Cancer Res; 2015 Jun; 21(11):2580-90. PubMed ID: 25739674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
    Ko YC; Choi HS; Liu R; Lee DS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Yes-associated Protein-1 in Gastrointestinal Cancers and Hepatocellular Carcinoma.
    Qian X; Zhang W; Yang H; Zhang L; Kang N; Lai J
    Explor Res Hypothesis Med; 2021 Sep; 6(3):110-117. PubMed ID: 34589656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development.
    Lv X; He C; Huang C; Wang H; Hua G; Wang Z; Zhou J; Chen X; Ma B; Timm BK; Maclin V; Dong J; Rueda BR; Davis JS; Wang C
    FASEB J; 2019 Sep; 33(9):10049-10064. PubMed ID: 31199671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.
    Dai Y; Liu S; Zhang WQ; Yang YL; Hang P; Wang H; Cheng L; Hsu PC; Wang YC; Xu Z; Jablons DM; You L
    Oncotarget; 2017 Jan; 8(3):4096-4109. PubMed ID: 27911857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
    García P; Rosa L; Vargas S; Weber H; Espinoza JA; Suárez F; Romero-Calvo I; Elgueta N; Rivera V; Nervi B; Obreque J; Leal P; Viñuela E; Aguayo G; Muñiz S; Sagredo A; Roa JC; Bizama C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.
    Diep CH; Zucker KM; Hostetter G; Watanabe A; Hu C; Munoz RM; Von Hoff DD; Han H
    PLoS One; 2012; 7(3):e32783. PubMed ID: 22396793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer.
    Kuser-Abali G; Alptekin A; Lewis M; Garraway IP; Cinar B
    Nat Commun; 2015 Sep; 6():8126. PubMed ID: 28230103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.
    Slemmons KK; Yeung C; Baumgart JT; Juarez JOM; McCalla A; Helman LJ
    Cancer Res; 2020 Jul; 80(14):3046-3056. PubMed ID: 32354737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.